ArticleCell & bioscience2024

Dihydroartemisinin restores the immunogenicity and enhances the anticancer immunosurveillance of cisplatin by activating the PERK/eIF2α pathway.

Yumei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.